Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BCL2L1 underexpression
i
Other names:
BCL2L1, Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52, BCL2-like 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
598
Related biomarkers:
Expression
Mutation
Others
‹
BCL2/BCL2L1 ratio elevation (3)
Chr t(11;14) + BCL2 : BCL2L1 ratio elevation (1)
BCL2/BCL2L1 ratio elevation (3)
Chr t(11;14) + BCL2 : BCL2L1 ratio elevation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BCL2L1 underexpression
Multiple Myeloma
BCL2L1 underexpression
Multiple Myeloma
bortezomib + A-1331852
Sensitive: D – Preclinical
bortezomib + A-1331852
Sensitive
:
D
bortezomib + A-1331852
Sensitive: D – Preclinical
bortezomib + A-1331852
Sensitive
:
D
BCL2L1 underexpression
T Acute Lymphoblastic Leukemia
BCL2L1 underexpression
T Acute Lymphoblastic Leukemia
venetoclax + NBL-001
Sensitive: D – Preclinical
venetoclax + NBL-001
Sensitive
:
D
venetoclax + NBL-001
Sensitive: D – Preclinical
venetoclax + NBL-001
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login